 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval" y; v4 U8 \9 z x7 l" C+ ?. j
. b/ J3 B( ^* ]EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.- b; m! Q& C/ h P; X7 u6 `
0 l. R+ @& ]" o' V# W. M9 KBY THE EDMONTON JOURNAL FEBRUARY 16, 2007& `) \0 G- Q9 C& U2 N0 R# R/ q
1 y, e& q8 B0 @- f* L: [ - u( X; o a' R! Q; C; H
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.. n. S9 r" E7 C( d( y* B) J0 y, O
( `9 W, l+ j' Q U
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
$ R) a U) s3 U% G
! P3 x( e3 M8 y" `; KThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
2 w% ~4 b* k u: ]2 O: D: D7 X, [1 Z' ?3 }# ]0 P/ V
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.+ ~3 |* W: A# F4 j6 v% ~- S
4 `2 B/ b) ]) J( n$ f1 D
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
- I6 ]% l: ]/ i0 o+ _& C7 d2 N' B8 Z' E6 b7 h# P
"As a scientist, it's one of the highlights of my CAREER," Shan said.
- j5 ] j( }2 B S: Q4 W* m5 Z: D2 j$ L
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."& x- ]1 R3 m& o( ^4 K/ {% P, Z7 U
6 T# |9 P9 v: I9 p( W+ Y/ }9 `9 P4 e
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
% ]" Y1 ?' ~- L' y+ P0 G* T& n( c3 p/ {# S
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
; o1 `3 V" J* E4 E: j* N
+ q) @1 ~9 J X5 ?3 NThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
! z8 O+ ?7 b, Q6 R
; q8 V+ x" f0 l, V2 b. m6 Z) |8 c" \! P2 q1 {: y: l3 d
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|